FADS2 and acute myeloid leukemia: Lipidomics analysis has revealed increased levels of phospholipids containing triglycerides and also increased levels of phospholipids containing PUFAs with three unsaturated bonds in imetelstat-treated AML cells in an FADS2-dependent manner.